China fines British pharmaceutical firm for bribery
China has fined the giant pharmaceutical firm of the UK, GlaxoSmithKline (GSK), USD 490mn for bribing doctors and hospitals in order to have their products promoted.
The court gave its sentence after a one-day trial at a court in Changsha, China.
GSK’s former head of Chinese operations, Mark Reilly, received a suspended three-year prison and he is set to be deported. Other GSK executives have also been given suspended jail sentences.
The scandal has become the biggest corruption scandal to hit a foreign firm in years, with the company being alleged for having made an estimated USD 150mn in illegal profits.
GSK has published a statement of apology to the Chinese government and its people.
Related Articles
Several Roads under CPEC in Their Final Phase: Pakistani Official
Pakistan will start reaping the benefits of the second phase of the China-Pakistan Economic Corridor (CPEC) in the form of
Narendra Modi’s suit sold for over USD 690,000
Indian Prime Minister Narendra Modi’s suit was sold for Rs 4.31 crore (USD 693,234) at an auction to Surat diamond
Greek to be assessed on its debt reduction progress
Creditors from the troika (made up of the International Monetary Fund (IMF), European Central Bank (ECB), and the European Commission
